Press release
AmeraCell Bio Hacking with Wharton's Jelly IV Therapy
Fairfax Virginia - AmeraCell, [https://ameracell.com/]a leading provider of regenerative medicine solutions, is proud to announce the launch of its innovative Wharton's Jelly IV therapy. This groundbreaking treatment harnesses the power of mesenchymal stem cells (MSCs), cellular solutions, and exosomes to promote overall wellness and address various health conditions.
About Wharton's Jelly IV Therapy
Wharton's Jelly, a gelatinous substance extracted from umbilical cords, is rich in MSCs, growth factors, and other beneficial compounds. AmeraCell's proprietary IV therapy utilizes this potent mixture to deliver a concentrated dose of regenerative cells and signals directly into the bloodstream.
"As Chief Medical Officer at AmeraCell, I am thrilled to introduce our innovative matrix of micro a nano particles in our IV therapy to the medical community. This groundbreaking treatment has the potential to revolutionize the way we approach regenerative medicine, and I am eager to see the positive impact it will have on our patients' lives." - Dr. Naveen Doki
Benefits of Wharton's Jelly IV Therapy
- Enhances overall wellness and vitality
- Supports tissue repair and regeneration
- May improve symptoms of chronic conditions, such as arthritis and autoimmune disorders
- Boosts immune system function
What Sets AmeraCell Apart
AmeraCell's commitment to quality, safety, and innovation has earned it a reputation as a leader in the regenerative medicine field. Our Wharton's Jelly IV therapy is:
- Derived from ethically sourced, screened, and tested umbilical cords
- Processed in a state-of-the-art, FDA-registered facility
- Administered by experienced healthcare professionals in a clinical setting
About AmeraCell
AmeraCell is a pioneering regenerative medicine company dedicated to providing cutting-edge therapies that improve human health and quality of life. Our mission is to empower individuals to take control of their wellness journey through innovative, safe, and effective treatments.
Contact Information
To learn more about AmeraCell's Wharton's Jelly IV therapy or to schedule a consultation, please visit our website at AmeraCell.com or contact us directly:
Phone: 407 801 2269
Email: AmeraCellClinics@Gmail.com
Note to editors:
For high-resolution images, interview requests, or additional information, please contact AmeraCell [https://ameracell.com/] at AmeracellClinics@gmail.com [mailto:AmeracellClinics@gmail.com].
Media Contact
Company Name: AmeraCell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ameracell-bio-hacking-with-whartons-jelly-iv-therapy]
Address:300 N Atlantic Ave #108
City: Cocoa Beach
State: FL 32931
Country: United States
Website: https://ameracell.com/pharmacy
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AmeraCell Bio Hacking with Wharton's Jelly IV Therapy here
News-ID: 3826043 • Views: …
More Releases from ABNewswire
China In-Vitro Diagnostics Market size to Reach USD 24.92 Billion by 2031, Drive …
Mordor Intelligence has published a new report on the china in-vitro diagnostics market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
According to Mordor Intelligence, the china in-vitro diagnostics market size [https://www.mordorintelligence.com/industry-reports/china-in-vitro-diagnostics-market?utm_source=abnewswire] is projected to reach USD 24.92 billion by 2031, growing from USD 19.57 billion in 2026 at a CAGR of 4.95% during the forecast period. The china in-vitro diagnostics market size reflects steady expansion supported by…
Hyaluronic Acid Market Size to Reach USD 4.07 Billion by 2030 - Mordor Intellige …
Mordor Intelligence has released an in-depth analysis of the hyaluronic acid market, outlining expanding cosmetic, orthopedic, and pharmaceutical applications driving global demand.
Hyaluronic Acid Market Overview
According to Mordor Intelligence, the global hyaluronic acid market size [https://www.mordorintelligence.com/industry-reports/hyaluronic-acid-market?utm_source=abnewswire] reached USD 2.84 billion in 2025 and is projected to grow to USD 4.07 billion by 2030, registering a CAGR of 7.46% during the forecast period.
The strong hyaluronic acid market growth is supported by:
* Increasing…
Scott Bryant Unveils Moon Valley's "Best Value" Listing in Hillcrest East; Signa …
Bryant Real Estate Leverages Data-Driven Performance Metrics to Position New Hillcrest East Property as the Region's Premier Investment Opportunity
PHOENIX, AZ - Scott Bryant, Founder and Team Leader of Bryant Real Estate and a top-performing agent with Keller Williams, has announced the debut of a landmark listing in the Hillcrest East subdivision of Moon Valley. Positioned as "Moon Valley's Best Deal," the property is being introduced at a strategic price point…
Jennifer Rollin Named Best Individual Therapist in Best of Bethesda Awards
Bethesda, MD, USA - Jennifer Rollin, LCSW-C, eating disorder therapist and founder of The Eating Disorder Center, has been named Best Individual Therapist in the 2025 Best of Bethesda Awards. She was selected from among therapists across Montgomery County, Maryland and Upper Northwest Washington, D.C., an honor that reflects both community support and her longstanding commitment to helping individuals recover from eating disorders.
Jennifer Rollin provides eating disorder therapy [https://www.theeatingdisordercenter.com/eatingdisordertherapyrockvilleservices.html] in…
More Releases for AmeraCell
AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions
Image: https://www.abnewswire.com/upload/2025/02/289e8b2e1d891a628fce90b1532c39f3.jpg
Fairfax, VA - AmeraCell, a leading provider of life science medicines, is pleased to announce that it has signed a Letter of Intent (LOI) with StemWave, a pioneering provider of non-invasive pain management solutions.
This strategic partnership aims to provide patients with cutting-edge regenerative medicine solutions for pain management, leveraging the expertise of both organizations.
"We are thrilled to partner with StemWave to offer our patients innovative pain management options," said…
AmeraCell Launches Revolutionary Wharton's Jelly MSc IV Therapy for Advanced Wel …
Image: https://www.abnewswire.com/upload/2025/01/9c6215166ea166a615398ac58e4d78ef.jpg
Fairfax, Virginia - AmeraCell [https://ameracell.com/], a Life Science Clinic, is proud to announce the launch of its groundbreaking Wharton's Jelly MSc IV therapy. This innovative treatment utilizes the regenerative power of Wharton's jelly, cellular solutions, and mesenchymal cells to enhance overall wellness and address various chronic health conditions.
Wharton's Jelly MSc therapy is derived from ethically sourced umbilical cords. It is rich in Wharton's jelly, growth factors, and other bioactive…
AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chi …
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXf6lnWBjHtv1vNESJODCnyAI57Da6r_Bsny_CRL1HkRArIePBqhfHdc8E-3Mgv1srSjvPOZ0kOPN5esunTJVx31kwbLHZ4FGlGNuQxjEUfHP-Zx61Epyfu5917VDsN1YeM0FvdySA?key=pfjRRuJ_S4XBBGPHHK1PXqNz
New York New York - AmeraCell [https://ameracell.com/], a cutting-edge life science company, announced today the appointment of Naveen Doki, MD, as its Chief Medical Officer (CMO). Dr. Doki brings over a decade of experience in oncology and hematology from the DC Metro area to his new role.
As CMO, Dr. Doki will spearhead the development and implementation of AmeraCell's medical strategies, ensuring the company remains at the forefront of regenerative…
AmeraCell Solidifies Leadership in Life Sciences with Plans for Innovation and E …
Image: https://www.abnewswire.com/upload/2025/01/362d0397e292acf147cd220e0ad40f81.jpg
Washington, D.C. - January 2, 2025 - AmeraCell [https://ameracell.com/], a pioneering name in the life sciences sector, is proud to announce its continued success in 2024, solidifying its reputation as an industry leader. With a network of eight strategic locations across the United States, AmeraCell continues to redefine healthcare innovation and deliver exceptional patient outcomes. The company remains dedicated to improving lives through groundbreaking health solutions and personalized care.
Reflecting…
AmeraCell Accessible Affordable Bio Hacking in Katy Texas an American Life Scien …
Image: https://www.abnewswire.com/uploads/c46306625cd5028d1dcf9ba4de05042c.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
AmeraCell Bio Hacking in Katy, Texas with Cutting-Edge Life Science Solutions
Image: https://www.abnewswire.com/uploads/79e38f5d5a8c3789b9f55057ecaf6d44.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
